Optimal management of severe symptomatic gastroesophageal reflux disease.

Talley, N J; Zand Irani, M

Talley, N J; Zand Irani, M.

Affiliation

Talley NJ; From the, NHMRC Centre of Research Excellence of Digestive Health, Faculty of Health and Medicine, University of Newcastle, New Lambton Heights, NSW, Australia.
Zand Irani M; Hunter Medical Research Institute, New Lambton Heights, NSW, Australia.

J Intern Med ; 289(2): 162-178, 2021 02.

Article in En | MEDLINE | ID: mdl-32691466

Subject(s)

Gastroesophageal Reflux/diagnosis; Gastroesophageal Reflux/drug therapy; Alginates/therapeutic use; Antidepressive Agents/therapeutic use; Baclofen/therapeutic use; Bile Acids and Salts/metabolism; Breathing Exercises; Diagnosis, Differential; Endoscopy, Gastrointestinal; Gastroesophageal Reflux/physiopathology; Gastrointestinal Agents/therapeutic use; Histamine H2 Antagonists/therapeutic use; Humans; Hydrogen-Ion Concentration; Muscle Relaxants, Central/therapeutic use; Phenotype; Proton Pump Inhibitors/therapeutic use

Key words

functional dyspepsia; functional heartburn; fundoplication; gastroesophageal reflux disease; prokinetic; proton pump inhibitors; reflux hypersensitivity

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Gastroesophageal Reflux Type of study: Clinical_trials / Diagnostic_studies / Prognostic_studies Language: En Journal: J Intern Med Year: 2021 Type: Article Affiliation country: Australia

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google